Buy DYAI by Nov 8, 2026.

I've been digging into **Dyadic International (NASDAQ: DYAI)** and think it deserves a closer look from anyone researching small-cap biotech, micro-caps and emerging biomanufacturing companies. **This isn't a "DYAI is going to 10x tomorrow" post.** The interesting part to me is the underlying business transition and the number of different ways the technology could potentially create value. Here's what caught my attention: # 1. It's not a traditional binary biotech Dyadic isn't betting the company on getting **one drug** through …